Effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1, and oxidative stress in patients with a gout-a comparative study
African Health Sciences · 2025
DOI: 10.4314/ahs.v24i4.40 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift African Health Sciences, 2025. Verfasst von Ning Tie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Affiliated Hospital of Inner Mongolia Medical University, 010050, China. Hauptthemen laut MEDLINE: Oxidative Stress, Febuxostat, Uric Acid, Endothelin-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
The present comparative study aimed to investigate the effects of different doses of febuxostat on uric acid, inflammatory factors of serum, knee articular cavity, endothelin-1, and oxidative stress in patients with gout.
Methods
80 cases with hyperuricemia admitted to our hospital (January 2018- March 2020) were randomly distributed into two groups. The control group was administered 40 mg of febuxostat tablets daily., whereas the treatment group was administered febuxostat tablets 80 mg daily. Data were collected from two groups of patients, including uric acid level, TNF-α levels of serum and knee articular cavity, vascular endothelial function, and complications 1 month after the intervention.
Results
After data intervention, the levels of uric acid, TNF-α levels of serum, and knee articular cavity, NO, and SOD were signifi cantly different between the treatment group and the control group (each p< 0.05). There were no signifi cant differences in abdominal pain and diarrhea, liver damage, kidney damage, acute gout, and pruritus between the two groups (p >0.05). The duration of activity disorder, pain duration, and swelling in the treatment group were signifi cantly shorter than those in the control group (p< 0.05). The uric acid level was positively correlated with serum TNF-α level (p < 0.05), and negatively correlated with NO and SOD levels (p < 0.05).
Conclusion
For hyperuricemia-induced gout patients, taking a large dose of 80 mg febuxostat daily can signifi cantly reduce the uric acid level and inflammatory response, improve vascular endothelial function, enhance antioxidant ability, and improve the clinical symptoms of patients without increasing the adverse reactions to medication. Keywords: Febuxostat; hyperuricemia; gout; blood uric acid; serum inflammatory factors; inflammatory factors of knee articular cavity; endothelin 1; oxidative stress response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The Affiliated Hospital of Inner Mongolia Medical University, 010050, China.
- Clinical undergraduate class of 2015, Inner Mongolia Medical University, Inner Mongolia, 010050, China.
Zitieren
APA
Tie, N., Bai, L., Li, H., Man, D., Wang, L., Zhou, X., & Wang, Y. (2025). Effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1, and oxidative stress in patients with a gout-a comparative study. African Health Sciences. https://doi.org/10.4314/ahs.v24i4.40
Vancouver
Tie N, Bai L, Li H, Man D, Wang L, Zhou X, et al. Effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1, and oxidative stress in patients with a gout-a comparative study. African Health Sciences. 2025. doi:10.4314/ahs.v24i4.40
BibTeX
@article{Tie2025,
author = {Tie, Ning and Bai, Lijie and Li, Hongbin and Man, Dafu and Wang, Lei and Zhou, Xinlu and Wang, Yong},
title = {Effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1, and oxidative stress in patients with a gout-a comparative study},
journal = {African Health Sciences},
year = {2025},
doi = {10.4314/ahs.v24i4.40}
}
EUVIMED